These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 22807079)

  • 1. Don't just blame big pharma.
    Spence D
    BMJ; 2012 Jul; 345():e4825. PubMed ID: 22807079
    [No Abstract]   [Full Text] [Related]  

  • 2. The ethics of pharmaceutical industry gift-giving: the role of a professional association.
    Morin K; Morse LJ
    Am J Bioeth; 2003; 3(3):54-5. PubMed ID: 14594494
    [No Abstract]   [Full Text] [Related]  

  • 3. Big pharma and American psychiatry.
    Sharfstein SS
    J Nerv Ment Dis; 2008 Apr; 196(4):265-6. PubMed ID: 18414119
    [No Abstract]   [Full Text] [Related]  

  • 4. American academy of pain medicine ethics council statement on conflicts of interest: interaction between physicians and industry in pain medicine.
    Dubois MY;
    Pain Med; 2010 Feb; 11(2):257-62. PubMed ID: 19930112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 'One pill makes you larger...'. Don't be seduced by pharmaceutical companies.
    Mason DJ
    Am J Nurs; 2000 Dec; 100(12):7. PubMed ID: 11202788
    [No Abstract]   [Full Text] [Related]  

  • 6. Doctors and the drug industry: further thoughts for dealing with potential conflicts of interest?
    Alpert JS
    Am J Med; 2008 Apr; 121(4):253-5. PubMed ID: 18374678
    [No Abstract]   [Full Text] [Related]  

  • 7. Corporate moral culpability in health care: when the implications don't fit the crime.
    Harter TD
    Am J Bioeth; 2011 Sep; 11(9):12-3. PubMed ID: 21877964
    [No Abstract]   [Full Text] [Related]  

  • 8. [Has self-interest taken over ethics and morals within medicine?].
    Werkö L
    Lakartidningen; 2002 Aug; 99(35):3432-3. PubMed ID: 12362769
    [No Abstract]   [Full Text] [Related]  

  • 9. Ties that bind? The web of CME and medical industry profit.
    Busby J
    Tex Med; 1991 Aug; 87(8):38-46. PubMed ID: 1925989
    [No Abstract]   [Full Text] [Related]  

  • 10. Industry-to-physician marketing and the cost of prescription drugs.
    Chiong W
    Am J Bioeth; 2003; 3(3):W28-W29. PubMed ID: 14594480
    [No Abstract]   [Full Text] [Related]  

  • 11. Collaborations between surgeons and industry are productive and beneficial to patients.
    Nakayama D
    J Am Coll Surg; 2010 Jul; 211(1):146-7; author reply 147. PubMed ID: 20610270
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacists' and physicians' attitudes toward pharmaceutical marketing practices.
    Poirier TI; Giannetti V; Giudici RA
    Am J Hosp Pharm; 1994 Feb; 51(3):378-81. PubMed ID: 8160692
    [No Abstract]   [Full Text] [Related]  

  • 13. All rationalizations large and small.
    Goodman B
    Am J Bioeth; 2003; 3(3):57-8. PubMed ID: 14594496
    [No Abstract]   [Full Text] [Related]  

  • 14. [Marketing of the LIFE trial anticipates evaluation of the drug].
    Järhult B
    Lakartidningen; 2002 Apr; 99(17):1964. PubMed ID: 12043424
    [No Abstract]   [Full Text] [Related]  

  • 15. Nurses and the pharmaceutical industry: part 2.
    Olsen DP
    Am J Nurs; 2009 Feb; 109(2):86-7. PubMed ID: 19300016
    [No Abstract]   [Full Text] [Related]  

  • 16. The physician and the pharmaceutical industry: both must keep the patient's interests at heart.
    Ravindran GD
    Issues Med Ethics; 1999; 7(1):21-2. PubMed ID: 16320467
    [No Abstract]   [Full Text] [Related]  

  • 17. Rosiglitazone, marketing, and medical science.
    Moynihan R
    BMJ; 2010 Apr; 340():c1848. PubMed ID: 20375091
    [No Abstract]   [Full Text] [Related]  

  • 18. Readers' and author's responses to "Physicians for sale: how medical professional organizations exploit their members".
    Adler AC
    Medscape J Med; 2008; 10(10):233; author reply 233. PubMed ID: 19117082
    [No Abstract]   [Full Text] [Related]  

  • 19. Readers' and author's responses to "Physicians for sale: how medical professional organizations exploit their members".
    Coli R
    Medscape J Med; 2008; 10(10):233; author reply 233. PubMed ID: 19117081
    [No Abstract]   [Full Text] [Related]  

  • 20. Elsevier should divest itself of either its medical publishing or pharmaceutical services division.
    Jureidini J; Clothier R
    Lancet; 2009 Aug; 374(9687):375. PubMed ID: 19647600
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.